{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a6","columns":[{"gene":"","key":"population-2143b529a70f77b9d940","label":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","mondoId":"MONDO:0013158","onsetQualifier":null,"originColumnKey":"MONDO:0013158/OMIM:613154","originalViews":[{"key":"MONDO:0013158/OMIM:613154","label":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","scopeLabel":"OMIM:613154","sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"recordKeys":["0371454628fdcb54d44dbe0880c150e896ea2f340a57ebca24b9e3bf42587663","07458d35858a576950a55122540349ed394fc9316342a5a89955928eec28d0bb","0795e3af7f4dc429f24f0475457a10498c64659b1ea2959457327b633e1f02d7","0cf8f8abb974d4a7b7bd5c5753eea1f8ed5008371a2a1442a076803711c538f6","11cd86973b407d6dc7fd5c21a97cc061502f841590bb5a8878a75cea3088a327","26eaf59d471993111c2d0a843d49f56bf9df5bd0036370c6145749d57e2225db","475ade2ad5c9cdda3a5bff08aebfe0b894fcafcb117c6d57ec2fd4ee3dc7db20","5404d38b2e68988d805d4c6f6dbb756ae74a4c64ee2d285fb7c0da35c8878e94","5c264cf2393331297c6dfa07a733487a18318bcb50423eeccf25c4d56771576c","65d4819774856d55d392dada2a4d4201203510b78a80a5f4399e86a11b4f0d83","7292b57d436b1ebb017cfb1611c2682cb58376d95f4bed90d4750bff5aa1b1c7","77836e482fdec63dccb433e814674f61459a59c2837bd90e475ca71278dd6eaf","7980bd4fd971771cfad0eef7fb28d9a6cb1c7fb3c2268c7f4983bfa3e870c060","a44a6d6069093a607a807a668c3dbca8d17c46c67f1aea1d2975b17ea4972dc0","a47a0dcc4de78b2930cac0d727d14c7b76edccd82b9428370588e906a73ea170","af88f093171dc00cb55978a1a57fa0aedb415b7437901942a922627a5b1b64b8","b83460fd9f1c5421163e89788fa1d87b94437872f92bfdd850d88c97b4b3c549","c1173a1be2c2783e08e4d217732a566e3e896b4a898cc5cad5c60091ae0bf4a3","c3e9f33b28a39333d15c49b28e15308960efd871b6226f989cf857092eb21f58","db6c324b9ef927cc9719839ab1bcabe4267231d399a6a32fe49e5ee9b2fcc617","deb33266fde62fcfd0e2971283db58da7ac862b44598d4a519cab8353a8e8b65","ea5f982567882cd94e45bf70e9e9abb6130ebaeebb76abe73de8cf9306f89fc5","eb5476756503c332e331b29928bdf51b79e9316a6ea6b3718eda75b70656c588","eff34e363d378c12e927b1832fa9591593fecc257130a51fa9a4c96d1098c5a3","f2438fe0af9f95d00f042874ff9a2af8e96f72d7a4bb843588bf6c3b7d4cf369","fd532d4f20fd49b041dd47aedc950929ce2bfa93d4e0c37583f9c71733e3e539"],"recordQualifiers":{},"scopeLabel":"OMIM:613154","sourceIds":["OMIM:613154"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":["population-2143b529a70f77b9d940"],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":["HP:0007063","HP:0001284","HP:0001321","HP:0001305","HP:0000519","HP:0007082","HP:0031956"],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":19,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":26,"sourceGroups":{"omim":6,"published":20}},"features":[{"hpoId":"HP:0007063","label":"Aplasia of the inferior half of the cerebellar vermis","primary":true},{"hpoId":"HP:0001284","label":"Areflexia","primary":true},{"hpoId":"HP:0001321","label":"Cerebellar hypoplasia","primary":true},{"hpoId":"HP:0001305","label":"Dandy-Walker malformation","primary":true},{"hpoId":"HP:0000519","label":"Developmental cataract","primary":true},{"hpoId":"HP:0007082","label":"Dilated third ventricle","primary":true},{"hpoId":"HP:0031956","label":"Elevated circulating aspartate aminotransferase concentration","primary":true},{"hpoId":"HP:0003236","label":"Elevated circulating creatine kinase activity","primary":false},{"hpoId":"HP:0001371","label":"Flexion contracture","primary":false},{"hpoId":"HP:0001290","label":"Generalized hypotonia","primary":false},{"hpoId":"HP:0001263","label":"Global developmental delay","primary":false},{"hpoId":"HP:0000238","label":"Hydrocephalus","primary":false},{"hpoId":"HP:0012110","label":"Hypoplasia of the pons","primary":false},{"hpoId":"HP:0025435","label":"Increased circulating lactate dehydrogenase concentration","primary":false},{"hpoId":"HP:0100297","label":"Increased endomysial connective tissue","primary":false},{"hpoId":"HP:0001249","label":"Intellectual disability","primary":false},{"hpoId":"HP:0006956","label":"Lateral ventricle dilatation","primary":false},{"hpoId":"HP:0003560","label":"Muscular dystrophy","primary":false},{"hpoId":"HP:0000648","label":"Optic atrophy","primary":false},{"hpoId":"HP:0008081","label":"Pes valgus","primary":false},{"hpoId":"HP:0000580","label":"Pigmentary retinopathy","primary":false},{"hpoId":"HP:0011484","label":"Posterior synechiae of the anterior chamber","primary":false},{"hpoId":"HP:0007973","label":"Retinal dysplasia","primary":false},{"hpoId":"HP:0006829","label":"Severe muscular hypotonia","primary":false},{"hpoId":"HP:0007260","label":"Type II lissencephaly","primary":false},{"hpoId":"HP:0002119","label":"Ventriculomegaly","primary":false}],"ledeHtml":"An autosomal recessive muscular dystrophy caused by mutations in the LARGE gene. It is associated with characteristic brain and eye malformations, profound mental retardation, and death usually in the first years of life.","mondoId":"MONDO:0013158","node":{"canonicalSlug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a6","comparisons":[{"documentSha256":"59a43abadb437d52169bd3b93016f039b01b583d9a3f51f7ab54b92ed5849d22","key":"legacy-muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a6","kind":"legacy","label":"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6","memberIds":["MONDO:0013158"],"mondoId":"MONDO:0013158","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a6.59a43abadb437d52169bd3b93016f039b01b583d9a3f51f7ab54b92ed5849d22.json"},{"documentSha256":"3e6dbbe08f0a5fa15c27b0b79dcb961a4938dbbf1575c7160f22f97818090975","key":"expanded-muscle-eye-brain-disease","kind":"expanded","label":"muscle-eye-brain disease","memberIds":["MONDO:0009364","MONDO:0009667","MONDO:0009678","MONDO:0013154","MONDO:0013157","MONDO:0013158","MONDO:0014022","MONDO:0014071","MONDO:0014140","MONDO:0018939"],"mondoId":"MONDO:0018939","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-3e6dbbe08f0a5fa15c27.3e6dbbe08f0a5fa15c27b0b79dcb961a4938dbbf1575c7160f22f97818090975.json"},{"documentSha256":"9e938372c5990a8aec98ddb0d9e5fdd3c77080997548d471f74c9d4d55873bd8","key":"expanded-muscular-dystrophy-dystroglycanopathy","kind":"expanded","label":"muscular dystrophy-dystroglycanopathy","memberIds":["MONDO:0000171","MONDO:0000172","MONDO:0000173","MONDO:0009364","MONDO:0009667","MONDO:0009678","MONDO:0011688","MONDO:0011787","MONDO:0012138","MONDO:0012248","MONDO:0012699","MONDO:0013049","MONDO:0013154","MONDO:0013155","MONDO:0013156","MONDO:0013157","MONDO:0013158","MONDO:0013159","MONDO:0013160","MONDO:0013161","MONDO:0013162","MONDO:0013440","MONDO:0013835","MONDO:0013904","MONDO:0014022","MONDO:0014023","MONDO:0014071","MONDO:0014101","MONDO:0014120","MONDO:0014140","MONDO:0014141","MONDO:0014142","MONDO:0014474","MONDO:0014489","MONDO:0014683","MONDO:0018276","MONDO:0018278","MONDO:0018280","MONDO:0029135","MONDO:0033556"],"mondoId":"MONDO:0018276","url":"https://kcjyutqgtpgteszueluf.supabase.co/storage/v1/object/public/community-guides/learn-data/node-comparison-9e938372c5990a8aec98.9e938372c5990a8aec98ddb0d9e5fdd3c77080997548d471f74c9d4d55873bd8.json"}],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6","paragraphs":["An autosomal recessive muscular dystrophy caused by mutations in the LARGE gene. It is associated with characteristic brain and eye malformations, profound mental retardation, and death usually in the first years of life."],"scope":"exact","source":"MONDO","upstream":"NCIT:C126743","url":"https://monarchinitiative.org/MONDO:0013158"},"ownColumnKeys":["population-2143b529a70f77b9d940"],"publication":"published","relationships":[{"kind":"parent","label":"muscular dystrophy-dystroglycanopathy, type A","mondoId":"MONDO:0000171","slug":"muscular-dystrophy-dystroglycanopathy-type-a"},{"kind":"parent","label":"muscle-eye-brain disease","mondoId":"MONDO:0018939","slug":"muscle-eye-brain-disease"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/15626"}],"translation":"pending"},"records":[{"frequencyKind":"count","key":"0371454628fdcb54d44dbe0880c150e896ea2f340a57ebca24b9e3bf42587663","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0031956","is_excluded":false,"label":"Elevated circulating aspartate aminotransferase concentration","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"07458d35858a576950a55122540349ed394fc9316342a5a89955928eec28d0bb","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000519","is_excluded":false,"label":"Developmental cataract","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"0795e3af7f4dc429f24f0475457a10498c64659b1ea2959457327b633e1f02d7","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000580","is_excluded":false,"label":"Pigmentary retinopathy","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"0cf8f8abb974d4a7b7bd5c5753eea1f8ed5008371a2a1442a076803711c538f6","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001249","is_excluded":false,"label":"Intellectual disability","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"11cd86973b407d6dc7fd5c21a97cc061502f841590bb5a8878a75cea3088a327","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001321","is_excluded":false,"label":"Cerebellar hypoplasia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"26eaf59d471993111c2d0a843d49f56bf9df5bd0036370c6145749d57e2225db","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0003236","is_excluded":false,"label":"Elevated circulating creatine kinase activity","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"475ade2ad5c9cdda3a5bff08aebfe0b894fcafcb117c6d57ec2fd4ee3dc7db20","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0007260","is_excluded":false,"label":"Type II lissencephaly","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"5404d38b2e68988d805d4c6f6dbb756ae74a4c64ee2d285fb7c0da35c8878e94","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0011484","is_excluded":false,"label":"Posterior synechiae of the anterior chamber","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5c264cf2393331297c6dfa07a733487a18318bcb50423eeccf25c4d56771576c","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000648","is_excluded":false,"label":"Optic atrophy","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"65d4819774856d55d392dada2a4d4201203510b78a80a5f4399e86a11b4f0d83","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0025435","is_excluded":false,"label":"Increased circulating lactate dehydrogenase concentration","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"7292b57d436b1ebb017cfb1611c2682cb58376d95f4bed90d4750bff5aa1b1c7","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001290","is_excluded":false,"label":"Generalized hypotonia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"77836e482fdec63dccb433e814674f61459a59c2837bd90e475ca71278dd6eaf","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001263","is_excluded":false,"label":"Global developmental delay","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"7980bd4fd971771cfad0eef7fb28d9a6cb1c7fb3c2268c7f4983bfa3e870c060","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0002119","is_excluded":false,"label":"Ventriculomegaly","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a44a6d6069093a607a807a668c3dbca8d17c46c67f1aea1d2975b17ea4972dc0","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0006829","is_excluded":false,"label":"Severe muscular hypotonia","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"reported","key":"a47a0dcc4de78b2930cac0d727d14c7b76edccd82b9428370588e906a73ea170","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":null,"hpo_id":"HP:0003560","is_excluded":false,"label":"Muscular dystrophy","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"af88f093171dc00cb55978a1a57fa0aedb415b7437901942a922627a5b1b64b8","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0012110","is_excluded":false,"label":"Hypoplasia of the pons","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"b83460fd9f1c5421163e89788fa1d87b94437872f92bfdd850d88c97b4b3c549","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0007063","is_excluded":false,"label":"Aplasia of the inferior half of the cerebellar vermis","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c1173a1be2c2783e08e4d217732a566e3e896b4a898cc5cad5c60091ae0bf4a3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0000238","is_excluded":false,"label":"Hydrocephalus","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"c3e9f33b28a39333d15c49b28e15308960efd871b6226f989cf857092eb21f58","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0100297","is_excluded":false,"label":"Increased endomysial connective tissue","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"db6c324b9ef927cc9719839ab1bcabe4267231d399a6a32fe49e5ee9b2fcc617","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0007082","is_excluded":false,"label":"Dilated third ventricle","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"deb33266fde62fcfd0e2971283db58da7ac862b44598d4a519cab8353a8e8b65","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0001284","is_excluded":false,"label":"Areflexia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"reported","key":"ea5f982567882cd94e45bf70e9e9abb6130ebaeebb76abe73de8cf9306f89fc5","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"TAS","frequency_raw":null,"hpo_id":"HP:0001371","is_excluded":false,"label":"Flexion contracture","onset_id":null,"reference":"OMIM:613154","source_release":"2026-06-23"},"sourceGroups":["omim"]},{"frequencyKind":"count","key":"eb5476756503c332e331b29928bdf51b79e9316a6ea6b3718eda75b70656c588","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0006956","is_excluded":false,"label":"Lateral ventricle dilatation","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"eff34e363d378c12e927b1832fa9591593fecc257130a51fa9a4c96d1098c5a3","raw":{"aspect":"P","body_system":"nervous_system","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0001305","is_excluded":false,"label":"Dandy-Walker malformation","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"f2438fe0af9f95d00f042874ff9a2af8e96f72d7a4bb843588bf6c3b7d4cf369","raw":{"aspect":"P","body_system":"eye","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0007973","is_excluded":false,"label":"Retinal dysplasia","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"fd532d4f20fd49b041dd47aedc950929ce2bfa93d4e0c37583f9c71733e3e539","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"OMIM:613154","disease_name":"Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6","evidence":"PCS","frequency_raw":"1/2","hpo_id":"HP:0008081","is_excluded":false,"label":"Pes valgus","onset_id":null,"reference":"PMID:17436019","source_release":"2026-06-23"},"sourceGroups":["published"]}],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013158\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>NCIT:C126743</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An autosomal recessive muscular dystrophy caused by mutations in the LARGE gene. It is associated with characteristic brain and eye malformations, profound mental retardation, and death usually in the first years of life.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0013158\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"muscular-dystrophy-dystroglycanopathy-congenital-with-brain-and-eye-anomalies-type-a6","sourceDocuments":[{"name":"MONDO: muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0013158"}],"sourceNote":"","synonyms":["MDDGA6","muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) type A, 6","muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 6"],"takeawayHtml":"","title":"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A6"},"schemaVersion":1}
